Emodialisi

L'emodialisi è una terapia fisica sostitutiva della funzionalità renale somministrata a soggetti nei quali essa è criticamente ridotta (uremia), condizione che rappresenta lo stadio più grave dell'insufficienza renale.
Nell'emodialisi le prime due funzioni vengono svolte sottoponendo il sangue del paziente (da cui "emo") al principio fisico della dialisi. Esso viene fatto scorrere in un filtro in cui entra in contatto con una membrana semipermeabile attraverso cui passano solo (o almeno in maggior quantità) le sostanze tossiche che si desidera rimuovere. Il filtro consente, oltre alla rimozione di sostanze, anche il reintegro di radicali alcalini, quindi il riequilibrio acido-base.
L'ultima funzione in elenco riguarda la necessità di rimuovere i liquidi assunti attraverso l'alimentazione e non eliminati con la diuresi, che può essere estremamente ridotta o assente (anuria) nei soggetti nefropatici in fase terminale. Il metodo utilizzato è la ultrafiltrazione. (fonte: Wikipedia)
Comunicati Stampa

Global Hemodialysis Catheters Industry Report 2014

http://photos.prnewswire.com/prnh/20130307/600769The Global Hemodialysis Catheters Industry Report 2014 is a professional and in-depth study on the current state of the global hemodialysis catheters industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The hemodialysis catheters market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status. Development policies and plans are also discussed and manufacturing processes and cost structures analyzed.Hemodialysis catheters industry import/export consumption, supply and demand figures and cost price and production value gross margins are also provided. The report focuses on fifteen industry players providing information such as company profiles, product picture and specification, capacity production, price, cost, production value and contact information.... (PR Newswire - 09/12/2014) Leggi

Global and Chinese Hemodialysis Concentrates Industry Report 2014

     (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) (PR Newswire - 24/10/2014) Leggi

Quanta Appoints New Chief Financial Officer

Willem has almost twenty years of investment banking, executive management and private equity experience. Amongst his achievements, Willem was pivotal in the $1.6billion turnaround and public listing of FLAG Telecom and was co-founder and CFO of Arqaam Capital, one of the largest boutique investment banks based in Dubai. Prior to joining Quanta, he was Managing Director of a private investment office, Mercantile Group.  Additionally, he has also worked at the telecommunications firm Ameritech (SBC), as well the investment banks Deutsche Bank and Panmure Gordon. More recently, he led the acquisition and the subsequent merger of the real-estate agency Humberts with Chesterton. And further, as Deputy Chairman of the enlarged group Chesterton Humberts, Willem oversaw its growth into one of the largest real-estate agencies in the UK and supported its international expansion. (PR Newswire - 07/08/2014) Leggi

Major Step Towards Portable Artificial Kidney

Today three international innovators join forces to develop and deliver to patients the world's first portable artificial kidney. Debiotech of Switzerland, AWAK of Singapore and Neokidney Development, an initiative of the Dutch Kidney Foundation, have signed a joint venture agreement to complete a functional model in 2015. Clinical trials are planned for 2017. The portable artificial kidney will enable the frequent and longer home haemodialysis that significantly improves and extends patients' lives.  (PR Newswire - 23/05/2014) Leggi
1 2 3
Altri nomi: Haemodialysis